BMEA

Biomea Fusion, Inc.

Insider Trades

NameValueActionPriceLast Price
Valle FrancoChief Financial Officer
$55k12.5k shares
BuyJun 11, 2024
$4.43
$1.38
Hitchcock Michael J.M.Director
$101k10k shares
BuySep 30, 2024
$10.06
$1.38
Erdtmann Rainer MDirector, Officer: See Remarks
$44k40k shares
BuyNov 28, 2025
$1.10
$1.38
Erdtmann Rainer MDirector, Officer: See Remarks
$11k10k shares
BuyDec 1, 2025
$1.05
$1.38
Hitchcock Michael J.M.Director, Officer: Interim CEO
$99k100k shares
BuyDec 2, 2025
$0.9918
$1.38
Erdtmann Rainer MDirector, Officer: See Remarks
$43k30k shares
BuyDec 11, 2025
$1.43
$1.38

News

globenewswire.comBiomea Fusion Presents New Clinical and Translational Data for Icovamenib at the American Diabetes Association (“ADA”) 86th Scientific Sessions and Announces Expansion of Ongoing Phase I BMF-650 Studyglobenewswire.comJun 5globenewswire.comBiomea Fusion Presents New Clinical and Translational Data for Icovamenib at the American Diabetes Association (“ADA”) 86th Scientific Sessions and Announces Expansion of Ongoing Phase I BMF-650 Studyglobenewswire.comJun 5globenewswire.comBiomea Fusion Announces Research Collaboration with University of Leicester to Evaluate Icovamenib in Combination with Semaglutide in Obesityglobenewswire.comJun 3globenewswire.comBiomea Fusion to Participate at Upcoming Investor Conferencesglobenewswire.comMay 12globenewswire.comBiomea Fusion Reports First Quarter 2026 Financial Results and Corporate Highlightsglobenewswire.comMay 11